EOG Resources Inc vs Cassava Sciences Inc — how do they compare? EOG Resources Inc trades at $138.94 (market cap $73.22B), while Cassava Sciences Inc trades at $1.07 (market cap $53.14M). The key difference: EOG Resources Inc is far larger — about 1377.9× Cassava Sciences Inc's market cap, and EOG Resources Inc pays a 2.97% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| EOG | FLNA | |
|---|---|---|
Market Cap | $73.22B | $53.14M |
Sector | Energy | Health |
52-Week High | $149.89 | $4.64 |
52-Week Low | $101.78 | $1.09 |
Enterprise Value | $77.68B | -$33.43M |
Dividend Yield | 2.97% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Filana Therapeutics (FLNA) trades at $1.09, down 5.22% on the day, reflecting persistent operational losses despite recent earnings beats. The stock exhibits a strong bearish technical signal, with moving averages and oscillators aligned negatively. Fundamentally, the company is in a pre-revenue biotech development phase, evidenced by significant negative cash flow from operations (-$32.25M in 2025) and deeply negative profitability metrics (ROE: -79.59%). Recent news highlights continued focus on its Tuberous Sclerosis Complex (TSC)-related epilepsy program.
The outlook is bifurcated: a bullish analyst consensus (8 Buy, 4 Hold, 0 Sell) suggests optimism for the clinical pipeline, while severe financial burn and bearish technicals present substantial near-term risk. Investment opportunity hinges entirely on successful drug development, with significant dilution or financing risk as the company funds operations. The stock is suitable only for high-risk investors comfortable with binary clinical outcomes.
Trailing returns across standard periods
EOG Resources is an oil and gas producer with acreage in several U.S. shale plays, including the Permian Basin, the Eagle Ford, and the Bakken. At the end of 2021, it reported net proved reserves of 3.7 billion barrels of oil equivalent. Net production averaged 829 thousand barrels of oil equivalent per day in 2021 at a ratio of 72% oil and natural gas liquids and 28% natural gas.
Read more on EOG →Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →